Sleep Quality in Pregnancy and Its Impact on Pregnancy Outcomes

December 19, 2013 updated by: S.K.SHARMA, All India Institute of Medical Sciences, New Delhi

Hypothesis:Sleep Disorders are very common during pregnancy but the their exact role in causation of pregnancy related disorders is yet to be determined. OSA can complicate pregnancy given the risk factors of weight gain, upper displacement of the diaphragm, and hormonal-induced hyperaemia of the nasopharyngeal passages. SDB confers the risk of hypertensive disorders of pregnancy and is associated with adverse maternal and foetal outcomes.

The study would involve pregnant females which would be prospectively followed in pregnancy and post partum to know the prevalence of sleep disorders in pregnancy. Diagnosis of sleep disorders would be confirmed by overnight polysomnography and ambulatory blood pressure monitoring. Pregnancy outcomes, both maternal and fetal would be recorded and its relation with sleep disorders in pregnancy would be analysed.

Study Overview

Detailed Description

Objectives

  1. To assess sleep quality during pregnancy
  2. To know prevalence of various sleep disorders during pregnancy including restless leg syndrome, symptomatic obstructive sleep apnea etc.
  3. To study the effect of sleep disorders on maternal and fetal outcome
  4. To study the relation of obstructive sleep apnea with pregnancy induced hypertension.

Material & Methods

Study Design: Longitudinal prospective case-control study

  • Consecutive patients undergoing antenatal check up at the Antenatal Clinic at AIIMS hospital during will be evaluated using questionnaires for sleep quality. Preliminary screening question for sleep disturbance in pregnancy to all patients
  • Questionnaires used: Pittsburgh Sleep Quality Index (covers insomnia, RLS, snoring and sleep related breathing disorders); Epworth Sleepiness Score (for Excessive daytime sleepiness); Modified Wisconsin Score; Modified Berlin Questionnaires
  • To now association between Obstructive sleep apnea and pregnancy induced hypertension patients who develop symptomatic OSA will be offered polysomnographic evaluation during the second/third trimester.
  • An offer of similar services will be made to pregnant females who do not develop pregnancy induced hypertension at a similar gestational age.

Case: patient with OSA

Control: patients without OSA

  • We proposed to determine that what proportion of the cases were exposed to sleep disorders and what proportion are not.
  • We also planned to determine what proportion of controls is exposed and what proportion is not.

Cases and controls would be matched for age ,parity, BMI,previous h/o pre-eclampsia in first trimester.

Outcome parameters

  1. Prevalence of various sleep disorders in pregnancy
  2. Maternal outcome: Development of pregnancy induced hypertension (PIH), gestational diabetes mellitus, complicated pregnancy requiring admission, preterm delivery, ante-partum hemorrhage, delivery requiring intervention (Caesarian section, forceps/ventouse application)
  3. Fetal outcome: APGAR scores at 1 and 5 min, IUGR, IUD, low birth weight

Sample Size:

A sample of convenience of 200 patients (who respond to questionnaire) and satisfy inclusion and exclusion criteria will be followed up prospectively to assess the effect of sleep disorders on pregnancy outcome.As per estimates from literature sample size for case control part would be 20 for cases and 40 controls.

Investigation specifically related to projects:

  1. Using Somnomedic systems, GmbH polysomnography machine by trained staff nurses and technicians at:

    • Obstetrics ward, AIIMS hospital
    • Home based portable PSG in non admitted
  2. Ambulatory blood pressure by the Oscar 2™ system from SunTech Medical, USA. The Oscar 2 is clinically validated to all three internationally recognized standards.

    • British Hypertension Society1 (A/A)
    • European Society of Hypertension International Protocol2
    • AAMI SP103

    Patient comfort The Oscar 2 and the Orbit™ BP cuff make patient comfort a priority.

    • The SunTech Medical, Inc. patented Orbit cuff uses an innovative stretch-sleeve design to maintain cuff placement and promote patient comfort.
    • The Oscar 2 is a light, compact monitor that uses motion tolerant algorithms to reduce re-inflates and failed readings. The auto-intelligent inflation pressure also reduces measurement time, promoting patient comfort by controlling cuff inflation.
  3. Screening Polysomnography using Apnea linkTM PLUS

    • A quick and easy sleep-screening tool designed to help identify more patients at risk for obstructive sleep apnea (OSA).
    • A premium, compact device that can be used at home

Additional Investigation Required

  • Routine clinical antenatal examination
  • Blood pressure measurement
  • Blood parameters (done routinely in ANC)

    • Fasting blood sugar
    • Renal and hepatic function tests
    • Hemoglobin levels/s ferritin
    • Serum TSH levels
  • Urine examination

    • Routine and spot sample for protein.
  • Sonography: To rule out twin pregnancy and molar gestation/IUGR/Anomalies.
  • These investigations are routinely done in ante natal clinic at AIIMS.

Data Analysis

  • Data will be collected on a pre-designed proforma.
  • Statistical analysis will be performed using STATA 11 for Windows software (intercooled version, Stata Corporation, Houston, TX, USA).
  • After assessing for approximate normal distribution, all continuous variables will be summarized as mean ± SD or median (interquartile range).
  • Categorical variables will be expressed as n (%).
  • The cases and controls will be compared using unpaired t-test if the data was normally distributed and the Mann-Whitney U test if not.
  • A p values of <0.05 will be considered statistically significant.
  • Confounding factors influencing pregnancy outcomes will be subject to multivariate analysis to determine significance.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • New Delhi, India, 110029
        • Recruiting
        • All India Institute of Medical Sciences, New Delhi
        • Sub-Investigator:
          • Sanjeev Sinha, MD
        • Contact:
        • Sub-Investigator:
          • Abhimanyu Nehra, MBBS
        • Sub-Investigator:
          • Sunesh Kumar Jain, MD
        • Sub-Investigator:
          • Vishnubhatla Sreenivas, Ph.D
        • Sub-Investigator:
          • Manish Soneja, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion criteria

  • Age 20-45 years
  • Singleton pregnancy

Exclusion criteria

  • Known hypertensives i.e SBP>140/DBP>90/on anti-hypertensive medications prior to pregnancy
  • Known diabetics (FBS>100, 75 g OGTT positive/on medications)
  • Hypothyroidism
  • Chronic renal failure
  • Chronic liver disease
  • Twin pregnancy
  • Known systemic inflammatory condition e.g APLA Syndrome,SLE
  • Molar gestation
  • Patients on nephrotoxic medications e.g.NSAIDS
  • Exclusion criteria for case control part only.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: polysomnography and AMBP on pregnant females

Consecutive patients undergoing antenatal check up at the Antenatal Clinic at AIIMS hospital and obstetrics wards will be recruited and followed.Using Somnomedic systems, GmbH polysomnography machine by trained staff nurses and technicians at:

Obstetrics ward, AIIMS hospital

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Sleep quality in pregnancy and its association with pregnancy outcomes
Time Frame: from recruitment during pregnancy to 6 weeks post partum
from recruitment during pregnancy to 6 weeks post partum

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of patients who develop PIH and gestational diabetes
Time Frame: from recruitment to 6 weeks post partum
from recruitment to 6 weeks post partum

Other Outcome Measures

Outcome Measure
Time Frame
to know the prevalence of sleep disorders in pregnancy and post partum
Time Frame: from recruitment in pregnancy to 6 week post partum
from recruitment in pregnancy to 6 week post partum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Surendra K Sharma, MD, Ph.D., All India Institute of Medical Sciences, New Delhi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Anticipated)

March 1, 2014

Study Completion (Anticipated)

May 1, 2014

Study Registration Dates

First Submitted

December 2, 2013

First Submitted That Met QC Criteria

December 19, 2013

First Posted (Estimate)

December 20, 2013

Study Record Updates

Last Update Posted (Estimate)

December 20, 2013

Last Update Submitted That Met QC Criteria

December 19, 2013

Last Verified

December 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obstructive Sleep Apnea

Clinical Trials on Polysomnography and ambulatory blood pressure recording

3
Subscribe